Global News: Approval of PuraStat® for NHI Reimbursement

PuraStat®, absorbable haemostatic material, has been approved for the listing on Japan’s National Health Insurance Price List.  Effective from December 2021, Japanese medical institutions can claim reimbursement from NHI for the use of PuraStat in gastrointestinal endoscopic procedures. 

For more details, please refer to the press release on the corporate website.

http://www.3d-matrix.co.jp/en/dl_file/2021/3DM_2021_10_26_IR_001.pdf

Back to Blog